Objectives Occurrence of invasive fungal respiratory superinfections in patients with COVID‐
19 has gained increasing attention in the latest studies. Yet, description of acute invasive …

Abstract Mucormycosis, also called “Black Fungus”, is a new cause for worry in the current
Coronavirus disease 2019 (covid-19) pandemic. Mucormycosis is devasting due to its high …

The incidence rate of invasive mucormycosis (IM) in patients with hematological
malignancies (HMs) is increasing year by year, ranging from 0.07% to 4.29%, and the …

Background Direct neurological manifestations of coronavirus disease whether peripheral or
central are reported worldwide. Yet, along the 3rd wave of the pandemic especially in India …

COVID-19 is a pandemic disease which predominantly affects the respiratory system with
high critical care mortality and morbidity; however, it also causes multi-organ dysfunction in …

Although mucormycosis is an important cause of morbidity and mortality in children with
cancer, our understanding of the typical characteristics of these infections is incomplete. We …

COVID-19 continues to cause significant fatality worldwide. Glucocorticoids prove to play
essential roles in COVID-19 management; however, the extensive use of steroids together …

Background: Mucormycosis is classified as the third leading cause of invasive fungal
disease in immunocompromised patients and is characterized by high morbidity and …

Mucormycosis has emerged as an increasingly important cause of morbidity and mortality in
immunocompromised patients, but contemporary data in children are lacking. We conducted …

Mucormycosis is an invasive, life-threatening fungal infection that mainly affects
immunocompromised hosts. We collected data of pediatric mucormycosis cases from all 7 …